Uygulama Prensipleri: Lokal İlaçların Uygulama Prensipleri
Özet
Lokal ilaçların uygulama prensiplerini ele alan bu çalışma, ilacın doğrudan etki göstermesinin istendiği durumlarda tercih edilen lokal uygulamaların temel özelliklerini, farklı uygulama yollarını ve özellikle yoğun bakım hastalarındaki klinik önemini incelemektedir. İlaçların absorpsiyon süreci hastanın yaşı, vücut yüzey alanı, uygulama bölgesi ve ilacın kimyasal yapısına göre değişkenlik göstermektedir. Çalışmada epidermal, konjunktiva, intranazal, inhale, dış kulak yolu, bukkal, intratekal, intravajinal, rektal ve lezyon içi gibi çeşitli lokal uygulama yöntemleri ayrıntılı olarak ele alınmaktadır. Yoğun bakım hastalarında lokal uygulamalar, sistemik yan etkileri minimize ederek hızlı ve hedeflenmiş bir etki oluşturulmasını sağlar. Örneğin, epidermal uygulamalarda çocuklarda yan etki riski yüksekken, kritik hastalarda perfüzyon düşüklüğü emilimi azaltabilir. Benzer şekilde, göz ve burun yoluyla yapılan uygulamalarda sistemik dolaşıma geçişin engellenmesi için doğru tekniklerin kullanılması kritik önem taşır. İnhale tedavilerde nebülizatör seçimi ve filtre kullanımı hayati riskleri önlemede etkilidir. Sonuç olarak, multidisipliner bir yaklaşımla klinik pratik için en uygun lokal formülasyonların ve dozaj formlarının seçilmesi; tedavi maliyetini düşürmekte, yatış süresini kısaltmakta ve hastaların yaşam kalitesini artırmaktadır.
This study, which addresses the application principles of local drugs, examines the main characteristics of local applications preferred when a direct drug effect is desired, different administration routes, and their clinical importance, particularly in intensive care patients. The absorption process of drugs varies depending on the patient's age, body surface area, application site, and the chemical structure of the drug. The study discusses in detail various local administration methods such as epidermal, conjunctival, intranasal, inhaled, external ear canal, buccal, intrathecal, intravaginal, rectal, and intralesional. In intensive care patients, local applications provide rapid and targeted effects while minimizing systemic side effects. For instance, while the risk of side effects in epidermal applications is high in children, low perfusion in critically ill patients may reduce absorption. Similarly, using correct techniques in ocular and nasal administrations is critical to prevent transition into systemic circulation. In inhaled therapies, the choice of nebulizer and filter use are effective in preventing life-threatening risks. In conclusion, selecting the most appropriate local formulations and dosage forms for clinical practice through a multidisciplinary approach reduces treatment costs, shortens hospitalization, and improves patients' quality of life.
Referanslar
Kayaalp O. Akılcı Tedavi Yönünden Tıbbi Farmakoloji. In Ş. Oktay & O. Kayaalp (Eds.), İlaç Uygulama Yolları ve Uygulama Yerinden Absorbsiyon. Ankara, Pelikan Yayıncılık. 2012: 16-18.
https://clinicalgate.com/topical-and-transdermal-drug-delivery/ (Erişim tarihi: 04.04.2021).
Jacobi J. Corticosteroid Replacement in Critically Ill Patients. In: Martin SJ, editor. Critical Care Clinics. 22. Ohio, USA: Elsevier Saunders; 2006. p. 245-53.
Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54(1):1-15; quiz 6-8.
Vatti RR, Ali F, Teuber S, Chang C, Gershwin ME. Hypersensitivity reactions to corticosteroids. Clin Rev Allergy Immunol. 2014;47(1):26-37.
Leppert W, Malec-Milewska M, Zajaczkowska R, Wordliczek J. Transdermal and topical drug administration in the treatment of pain. Molecules. 2018;23(3).
Fernandez-Gines FD, Cortinas-Saenz M, Agudo-Ponce D, Navajas-Gomez de Aranda A, Morales-Molina JA, Fernandez-Sanchez C, et al. Pain reduction of topical sevoflurane vs intravenous opioids in pressure ulcers. Int Wound J. 2020;17(1):83-90.
Gazzabin L, Serantoni S, Palumbo FP, Giordan N. Hyaluronic acid and metallic silver treatment of chronic wounds: healing rate and bacterial load control. J Wound Care. 2019;28(7):482-90.
Najafi E, Ahmadi M, Mohammadi M, Beigmohammadi MT, Heidary Z, Vatanara A, et al. Topical pentoxifylline for pressure ulcer treatment: a randomised, double-blind, placebo-controlled clinical trial. J Wound Care. 2018;27(8):495-502.
Farsaei S, Khalili H, Farboud ES, Karimzadeh I, Beigmohammadi MT. Efficacy of topical atorvastatin for the treatment of pressure ulcers: a randomized clinical trial. Pharmacotherapy. 2014;34(1):19-27.
Kruer RM, Jarrell AS, Latif A. Reducing medication errors in critical care: a multimodal approach. Clin Pharmacol. 2014;6:117-26.
American Society of Anesthesiologists Task Force on Acute Pain M. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2012;116(2):248-73.
Jinagal J, Gupta PC, Pilania RK, Ram J. Systemic toxicity of topical corticosteroids. Indian J Ophthalmol. 2019;67(4):559-61.
Kiryazov K, Stefova M, Iotova V. Can ophthalmic drops cause central nervous system depression and cardiogenic shock in infants? Pediatr Emerg Care. 2013;29(11):1207-9.
McCall K, Hussin HM, Gregory ME, Dutton G, Richardson J. A bundle improves eye care in PICU. Arch Dis Child. 2016;101(9):832-5.
de Araujo DD, Silva DVA, Rodrigues CAO, Silva PO, Macieira TGR, Chianca TCM. Effectiveness of nursing interventions to prevent dry eye in critically ill patients. Am J Crit Care. 2019;28(4):299-306.
Bendavid I, Avisar I, Serov Volach I, Sternfeld A, Dan Brazis I, Umar L, et al. Prevention of exposure keratopathy in critically ill patients: A single-center, randomized, pilot trial comparing ocular lubrication with bandage contact lenses and punctal plugs. Crit Care Med. 2017;45(11):1880-6.
Luyt CE, Hekimian G, Brechot N, Chastre J. Aerosol therapy for pneumonia in the intensive care unit. Clin Chest Med. 2018;39(4):823-36.
Dhand R. The role of aerosolized antimicrobials in the treatment of ventilator-associated pneumonia. Respir Care. 2007;52(7):866-84.
Kola M, Hacioglu D, Erdol H, Turk A. Bilateral acute angle closure developing due to use of ipratropium bromide and salbutamol. Int Ophthalmol. 2018;38(1):385-8.
Luyt CE, Brechot N, Combes A, Trouillet JL, Chastre J. Delivering antibiotics to the lungs of patients with ventilator-associated pneumonia: an update. Expert Rev Anti Infect Ther. 2013;11(5):511-21.
Lu Q, Yang J, Liu Z, Gutierrez C, Aymard G, Rouby JJ, et al. Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Am J Respir Crit Care Med. 2011;184(1):106-15.
Moradi Moghaddam O, Niakan Lahiji M, Talebi-Taher M, Mahmoodiyeh B. Effect of inhaled colistin on the treatment of ventilator-associated pneumonia due to multi-drug resistant acinetobacter. Tanaffos. 2019;18(1):66-73.
Demirdal T, Sari US, Nemli SA. Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii? Ann Clin Microb Anti. 2016;15.
Karvouniaris M, Makris D, Zygoulis P, Triantaris A, Xitsas S, Mantzarlis K, et al. Nebulised colistin for ventilator-associated pneumonia prevention. Eur Respir J. 2015;46(6):1732-9.
Palmer LB, Smaldone GC. Reduction of bacterial resistance with inhaled antibiotics in the intensive care unit. Am J Respir Crit Care Med. 2014;189(10):1225-33.
Radigan EA, Gilchrist NA, Miller MA. Management of aminoglycosides in the intensive care unit. J Intensive Care Med. 2010;25(6):327-42.
Mercadante S, Ferrera P, Arcuri E. The use of fentanyl buccal tablets as breakthrough medication in patients receiving chronic methadone therapy: an open label preliminary study. Supportive Care in Cancer. 2011;19(3):435-8.
Gilbar PJ. Intrathecal chemotherapy potential for medication error. Cancer Nurs. 2014;37(4):299-309.
Nabavi SM, Arab L, Jarooghi N, Bolurieh T, Abbasi F, Mardpour S, et al. Safety, feasibility of intravenous and intrathecal injection of autologous bone marrow derived mesenchymal stromal cells in patients with amyotrophic lateral sclerosis: An open label phase I clinical trial. Cell J. 2019;20(4):592-8.
Singh K, Fong YF, Prasad RN, Dong F. Does an acidic medium enhance the efficacy of vaginal misoprostol for pre-abortion cervical priming? Hum Reprod. 1999;14(6):1635-7.
Kussmann M, Baumann A, Hauer S, Pichler P, Zeitlinger M, Wiesholzer M, et al. Compatibility of fosfomycin with different commercial peritoneal dialysis solutions. Eur J Clin Microbiol Infect Dis. 2017;36(11):2237-42.
Orlowski JP. Emergency alternatives to intravenous access. Intraosseous, intratracheal, sublingual, and other-site drug administration. Pediatr Clin North Am. 1994;41(6):1183-99.
Di Renzo GC, Al Saleh E, Mattei A, Koutras I, Clerici G. Use of tocolytics: what is the benefit of gaining 48 hours for the fetus? BJOG. 2006;113 Suppl 3:72-7.
De Maria M, Mogorovich A, Giannarini G, Manassero F, Selli C. Lidocaine-prilocaine administration during transrectal ultrasound-guided prostatic biopsy: a randomized, single-blind, placebo-controlled trial. J Endourol. 2006;20(7):525-9.
Tallab TM, Bahamdam KA, Mirdad S, Johargi H, Mourad MM, Ibrahim K, et al. Cutaneous leishmaniasis: schedules for intralesional treatment with sodium stibogluconate. Int J Dermatol. 1996;35(8):594-7.
